{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:19:35Z","timestamp":1790651975234,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,7,11]],"date-time":"2015-07-11T00:00:00Z","timestamp":1436572800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National the 12th Five-Year Plan Science and Technology support project \u2018\u2018clinical epidemiological studies of optic neuritis","award":["2012BAI08B06"],"award-info":[{"award-number":["2012BAI08B06"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2013M532109"],"award-info":[{"award-number":["2013M532109"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00415-015-7844-y","type":"journal-article","created":{"date-parts":[[2015,7,9]],"date-time":"2015-07-09T23:49:48Z","timestamp":1436485788000},"page":"2293-2304","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Features of anti-aquaporin 4 antibody-seropositive Chinese patients with neuromyelitis optica spectrum optic neuritis"],"prefix":"10.1007","volume":"262","author":[{"given":"Hongyang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quangang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanfen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,11]]},"reference":[{"issue":"9","key":"7844_CR1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","volume":"326","author":"RW Beck","year":"1992","unstructured":"Beck RW, Cleary PA, Anderson MM Jr, Keltner JL, Shults WT, Kaufman DI, Buckley EG, Corbett JJ, Kupersmith MJ, Miller NR et al (1992) A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Eng J Med 326(9):581\u2013588","journal-title":"N Eng J Med"},{"issue":"9349","key":"7844_CR2","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(02)11919-2","volume":"360","author":"SJ Hickman","year":"2002","unstructured":"Hickman SJ, Dalton CM, Miller DH, Plant GT (2002) Management of acute optic neuritis. Lancet 360(9349):1953\u20131962","journal-title":"Lancet"},{"issue":"16","key":"7844_CR3","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1212\/WNL.0b013e3181f8832e","volume":"75","author":"J Shimizu","year":"2010","unstructured":"Shimizu J, Hatanaka Y, Hasegawa M, Iwata A, Sugimoto I, Date H, Goto J, Shimizu T, Takatsu M, Sakurai Y et al (2010) IFNbeta-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum. Neurology 75(16):1423\u20131427","journal-title":"Neurology"},{"issue":"9","key":"7844_CR4","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1001\/archneurol.2009.178","volume":"66","author":"A McKeon","year":"2009","unstructured":"McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Hinson SR, Kryzer TJ, Lucchinetti CF, Weinshenker BG, Wingerchuk DM, Shuster EA et al (2009) Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays. Arch Neurol 66(9):1134\u20131138","journal-title":"Arch Neurol"},{"issue":"Pt 5","key":"7844_CR5","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/brain\/awm062","volume":"130","author":"T Takahashi","year":"2007","unstructured":"Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, Watanabe S, Shiga Y, Kanaoka C, Fujimori J et al (2007) Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain J Neurol 130(Pt 5):1235\u20131243","journal-title":"Brain J Neurol"},{"issue":"20","key":"7844_CR6","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1212\/WNL.0b013e3182563b32","volume":"78","author":"C Costa","year":"2012","unstructured":"Costa C, Arrambide G, Tintore M, Castillo J, Sastre-Garriga J, Tur C, Rio J, Saiz A, Vidal-Jordana A, Auger C et al (2012) Value of NMO-IgG determination at the time of presentation as CIS. Neurology 78(20):1608\u20131611","journal-title":"Neurology"},{"issue":"3","key":"7844_CR7","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00415-010-5780-4","volume":"258","author":"G Akman-Demir","year":"2011","unstructured":"Akman-Demir G, Tuzun E, Waters P, Icoz S, Kurtuncu M, Jarius S, Yapici Z, Mutlu M, Yesilot N, Vincent A et al (2011) Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients. J Neurol 258(3):464\u2013470","journal-title":"J Neurol"},{"issue":"1","key":"7844_CR8","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jocn.2012.06.006","volume":"20","author":"Y Yang","year":"2013","unstructured":"Yang Y, Huang DH, Wu WP, Wu L, Chen LF, Wu Q (2013) The role of aquaporin-4 antibodies in Chinese patients with neuromyelitis optica. J Clin Neurosci 20(1):94\u201398","journal-title":"J Clin Neurosci"},{"issue":"1","key":"7844_CR9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/WNO.0b013e3181f8a693","volume":"31","author":"C Lai","year":"2011","unstructured":"Lai C, Tian G, Takahashi T, Liu W, Yang L, Zhang X (2011) Neuromyelitis optica antibodies in patients with severe optic neuritis in China. J Neuro Ophthalmol 31(1):16\u201319","journal-title":"J Neuro Ophthalmol"},{"issue":"9","key":"7844_CR10","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/jnnp.2005.080390","volume":"77","author":"I Nakashima","year":"2006","unstructured":"Nakashima I, Fujihara K, Miyazawa I, Misu T, Narikawa K, Nakamura M, Watanabe S, Takahashi T, Nishiyama S, Shiga Y et al (2006) Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 77(9):1073\u20131075","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"18","key":"7844_CR11","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1212\/WNL.0b013e3182190f74","volume":"76","author":"N Asgari","year":"2011","unstructured":"Asgari N, Lillevang ST, Skejoe HP, Falah M, Stenager E, Kyvik KO (2011) A population-based study of neuromyelitis optica in Caucasians. Neurology 76(18):1589\u20131595","journal-title":"Neurology"},{"issue":"1","key":"7844_CR12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00415-004-0271-0","volume":"251","author":"A Ghezzi","year":"2004","unstructured":"Ghezzi A, Bergamaschi R, Martinelli V, Trojano M, Tola MR, Merelli E, Mancardi L, Gallo P, Filippi M, Zaffaroni M et al (2004) Clinical characteristics, course and prognosis of relapsing Devic\u2019s Neuromyelitis Optica. J Neurol 251(1):47\u201352","journal-title":"J Neurol"},{"issue":"5","key":"7844_CR13","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/1352458508101935","volume":"15","author":"DB Bichuetti","year":"2009","unstructured":"Bichuetti DB, Oliveira EM, Souza NA, Rivero RL, Gabbai AA (2009) Neuromyelitis optica in Brazil: a study on clinical and prognostic factors. Mult Scler 15(5):613\u2013619","journal-title":"Mult Scler"},{"issue":"1\u20132","key":"7844_CR14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jns.2010.07.011","volume":"298","author":"S Jarius","year":"2010","unstructured":"Jarius S, Frederikson J, Waters P, Paul F, Akman-Demir G, Marignier R, Franciotta D, Ruprecht K, Kuenz B, Rommer P et al (2010) Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis. J Neurol Sci 298(1\u20132):158\u2013162","journal-title":"J Neurol Sci"},{"issue":"1","key":"7844_CR15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/jnnp.2008.146894","volume":"81","author":"A Petzold","year":"2010","unstructured":"Petzold A, Pittock S, Lennon V, Maggiore C, Weinshenker BG, Plant GT (2010) Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis. J Neurol Neurosurg Psychiatry 81(1):109\u2013111","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"7844_CR16","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","volume":"6","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6(9):805\u2013815","journal-title":"Lancet Neurol"},{"issue":"6","key":"7844_CR17","doi-asserted-by":"crossref","first-page":"e99323","DOI":"10.1371\/journal.pone.0099323","volume":"9","author":"H Li","year":"2014","unstructured":"Li H, Zhang Y, Yi Z, Huang D, Wei S (2014) Frequency of autoantibodies and connective tissue diseases in Chinese patients with optic neuritis. PLoS One 9(6):e99323","journal-title":"PLoS One"},{"issue":"2","key":"7844_CR18","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292\u2013302","journal-title":"Ann Neurol"},{"issue":"10","key":"7844_CR19","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66(10):1485\u20131489","journal-title":"Neurology"},{"issue":"9","key":"7844_CR20","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62(9):2569\u20132581","journal-title":"Arthritis Rheum"},{"issue":"6","key":"7844_CR21","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS et al (2002) Classification criteria for Sjogren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61(6):554\u2013558","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"7844_CR22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10067-013-2444-7","volume":"33","author":"FY Gan","year":"2014","unstructured":"Gan FY, Fei YY, Li MT, Wang Q, Xu D, Hou Y, Zeng XF, Zhang FC (2014) The characteristics of patients having ankylosing spondylitis associated with Takayasu\u2019s arteritis. Clin Rheumatol 33(3):355\u2013358","journal-title":"Clin Rheumatol"},{"issue":"5","key":"7844_CR23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.autrev.2008.01.001","volume":"7","author":"J Castro","year":"2008","unstructured":"Castro J, Balada E, Ordi-Ros J, Vilardell-Tarres M (2008) The complex immunogenetic basis of systemic lupus erythematosus. Autoimmun Rev 7(5):345\u2013351","journal-title":"Autoimmun Rev"},{"issue":"6","key":"7844_CR24","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","volume":"116","author":"GS Hoffman","year":"1992","unstructured":"Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116(6):488\u2013498","journal-title":"Ann Intern Med"},{"issue":"8697","key":"7844_CR25","first-page":"1078","volume":"335","author":"International Study Group for Behcet\u2019s Disease","year":"1990","unstructured":"International Study Group for Behcet\u2019s Disease (1990) Criteria for diagnosis of Behcet\u2019s disease. Lancet 335(8697):1078\u20131080","journal-title":"Lancet"},{"issue":"2","key":"7844_CR26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4(2):295\u2013306","journal-title":"J Thromb Haemost"},{"issue":"5","key":"7844_CR27","doi-asserted-by":"crossref","first-page":"e10455","DOI":"10.1371\/journal.pone.0010455","volume":"5","author":"S Mader","year":"2010","unstructured":"Mader S, Lutterotti A, Di Pauli F, Kuenz B, Schanda K, Aboul-Enein F, Khalil M, Storch MK, Jarius S, Kristoferitsch W et al (2010) Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica. PLoS One 5(5):e10455","journal-title":"PLoS One"},{"issue":"Pt 2","key":"7844_CR28","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/brain\/114.2.1057","volume":"114","author":"BG Weinshenker","year":"1991","unstructured":"Weinshenker BG, Rice GP, Noseworthy JH, Carriere W, Baskerville J, Ebers GC (1991) The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials. Brain J Neurol 114(Pt 2):1057\u20131067","journal-title":"Brain J Neurol"},{"issue":"9","key":"7844_CR29","first-page":"612","volume":"3","author":"M Etemadifar","year":"2012","unstructured":"Etemadifar M, Abtahi MA, Razmjoo H, Abtahi SH, Dehghani AR, Abtahi ZA, Akbari M, Mazaheri S, Maghzi AH (2012) Anti-aquaporin-4 IgG in patients presenting with unilateral optic neuritis: a cohort study. Int J Prevent Med 3(9):612\u2013615","journal-title":"Int J Prevent Med"},{"issue":"4","key":"7844_CR30","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.neuroscience.2009.08.032","volume":"168","author":"SR Hinson","year":"2010","unstructured":"Hinson SR, McKeon A, Lennon VA (2010) Neurological autoimmunity targeting aquaporin-4. Neuroscience 168(4):1009\u20131018","journal-title":"Neuroscience"},{"issue":"23","key":"7844_CR31","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000303817.82134.da","volume":"70","author":"M Matiello","year":"2008","unstructured":"Matiello M, Lennon VA, Jacob A, Pittock SJ, Lucchinetti CF, Wingerchuk DM, Weinshenker BG (2008) NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 70(23):2197\u20132200","journal-title":"Neurology"},{"key":"7844_CR32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-9-14","volume":"9","author":"S Jarius","year":"2012","unstructured":"Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, Geis C, Kleiter I, Kleinschnitz C, Berthele A, Brettschneider J et al (2012) Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J Neuroinflammation 9:14","journal-title":"J Neuroinflammation"},{"issue":"6","key":"7844_CR33","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00415-006-0116-0","volume":"253","author":"H Koller","year":"2006","unstructured":"Koller H, Neuen-Jacob E, Saleh A, Kieseier BC, Jander S, Hartung HP (2006) A patient with a benign course of neuromyelitis optica (Devic\u2019s syndrome) over 12\u00a0years: mRI follow up and histological findings. J Neurol 253(6):819\u2013820","journal-title":"J Neurol"},{"issue":"7","key":"7844_CR34","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/archneurol.2011.127","volume":"68","author":"N Collongues","year":"2011","unstructured":"Collongues N, Cabre P, Marignier R, Zephir H, Papeix C, Audoin B, Lebrun-Frenay C, Pelletier J, Fontaine B, Vermersch P et al (2011) A benign form of neuromyelitis optica: does it exist? Arch Neurol 68(7):918\u2013924","journal-title":"Arch Neurol"},{"issue":"3","key":"7844_CR35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1600-0404.2010.01388.x","volume":"123","author":"J Burman","year":"2011","unstructured":"Burman J, Raininko R, Fagius J (2011) Bilateral and recurrent optic neuritis in multiple sclerosis. Acta Neurol Scand 123(3):207\u2013210","journal-title":"Acta Neurol Scand"},{"issue":"9","key":"7844_CR36","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/archneur.61.9.1401","volume":"61","author":"I Pirko","year":"2004","unstructured":"Pirko I, Blauwet LA, Lesnick TG, Weinshenker BG (2004) The natural history of recurrent optic neuritis. Arch Neurol 61(9):1401\u20131405","journal-title":"Arch Neurol"},{"issue":"6","key":"7844_CR37","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","volume":"58","author":"CH Polman","year":"2005","unstructured":"Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O\u2019Connor PW et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d. Ann Neurol 58(6):840\u2013846","journal-title":"Ann Neurol"},{"issue":"3","key":"7844_CR38","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1590\/S0004-27492013000300008","volume":"76","author":"FR Silva","year":"2013","unstructured":"Silva FR, Vidotti VG, Cremasco F, Dias M, Gomi ES, Costa VP (2013) Sensitivity and specificity of machine learning classifiers for glaucoma diagnosis using spectral domain OCT and standard automated perimetry. Arq Bras Oftalmol 76(3):170\u2013174","journal-title":"Arq Bras Oftalmol"},{"issue":"2","key":"7844_CR39","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ophtha.2013.09.035","volume":"121","author":"E Garcia-Martin","year":"2014","unstructured":"Garcia-Martin E, Polo V, Larrosa JM, Marques ML, Herrero R, Martin J, Ara JR, Fernandez J, Pablo LE (2014) Retinal layer segmentation in patients with multiple sclerosis using spectral domain optical coherence tomography. Ophthalmology 121(2):573\u2013579","journal-title":"Ophthalmology"},{"issue":"4","key":"7844_CR40","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1212\/WNL.0b013e3181af78b8","volume":"73","author":"JN Ratchford","year":"2009","unstructured":"Ratchford JN, Quigg ME, Conger A, Frohman T, Frohman E, Balcer LJ, Calabresi PA, Kerr DA (2009) Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology 73(4):302\u2013308","journal-title":"Neurology"},{"issue":"12","key":"7844_CR41","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1212\/01.wnl.0000345042.53843.d5","volume":"72","author":"RT Naismith","year":"2009","unstructured":"Naismith RT, Tutlam NT, Xu J, Klawiter EC, Shepherd J, Trinkaus K, Song SK, Cross AH (2009) Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology 72(12):1077\u20131082","journal-title":"Neurology"},{"issue":"4","key":"7844_CR42","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/WNO.0b013e318238b9cb","volume":"31","author":"RH Kardon","year":"2011","unstructured":"Kardon RH (2011) Role of the macular optical coherence tomography scan in neuro-ophthalmology. J Neuroophthalmol 31(4):353\u2013361","journal-title":"J Neuroophthalmol"},{"key":"7844_CR43","first-page":"41","volume":"7","author":"M Adawi","year":"2014","unstructured":"Adawi M, Bisharat B, Bowirrat A (2014) Systemic Lupus Erythematosus (SLE) complicated by Neuromyelitis Optica (NMO\u2014Devic\u2019s Disease): clinic-pathological report and review of the literature. Clin Me Insights Case Rep 7:41\u201347","journal-title":"Clin Me Insights Case Rep"},{"issue":"1","key":"7844_CR44","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12883-014-0200-5","volume":"14","author":"A Jayarangaiah","year":"2014","unstructured":"Jayarangaiah A, Sehgal R, Epperla N (2014) Sjogren inverted question marks syndrome and Neuromyelitis Optica spectrum disorders (NMOSD) inverted question mark a case report and review of literature. BMC Neurol 14(1):200","journal-title":"BMC Neurol"},{"issue":"6","key":"7844_CR45","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1177\/1352458508088941","volume":"14","author":"A Javed","year":"2008","unstructured":"Javed A, Balabanov R, Arnason BG, Kelly TJ, Sweiss NJ, Pytel P, Walsh R, Blair EA, Stemer A, Lazzaro M et al (2008) Minor salivary gland inflammation in Devic\u2019s disease and longitudinally extensive myelitis. Mult Scler 14(6):809\u2013814","journal-title":"Mult Scler"},{"issue":"6","key":"7844_CR46","doi-asserted-by":"crossref","first-page":"e65385","DOI":"10.1371\/journal.pone.0065385","volume":"8","author":"AJ Solomon","year":"2013","unstructured":"Solomon AJ, Hills W, Chen Z, Rosenbaum J, Bourdette D, Whitham R (2013) Autoantibodies and Sjogren\u2019s Syndrome in multiple sclerosis, a reappraisal. PLoS One 8(6):e65385","journal-title":"PLoS One"},{"issue":"4","key":"7844_CR47","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1212\/WNL.42.4.845","volume":"42","author":"M Sandberg-Wollheim","year":"1992","unstructured":"Sandberg-Wollheim M, Axell T, Hansen BU, Henricsson V, Ingesson E, Jacobsson L, Larsson A, Lieberkind K, Manthorpe R (1992) Primary Sjogren\u2019s syndrome in patients with multiple sclerosis. Neurology 42(4):845\u2013847","journal-title":"Neurology"},{"key":"7844_CR48","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1742-2094-7-52","volume":"7","author":"S Jarius","year":"2010","unstructured":"Jarius S, Franciotta D, Paul F, Ruprecht K, Bergamaschi R, Rommer PS, Reuss R, Probst C, Kristoferitsch W, Wandinger KP et al (2010) Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance. J Neuroinflammation 7:52","journal-title":"J Neuroinflammation"},{"issue":"1\u20132","key":"7844_CR49","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2011.03.038","volume":"306","author":"S Jarius","year":"2011","unstructured":"Jarius S, Paul F, Franciotta D, Ruprecht K, Ringelstein M, Bergamaschi R, Rommer P, Kleiter I, Stich O, Reuss R et al (2011) Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures. J Neurol Sci 306(1\u20132):82\u201390","journal-title":"J Neurol Sci"},{"key":"7844_CR50","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cca.2012.12.008","volume":"417","author":"KH Chang","year":"2013","unstructured":"Chang KH, Tseng MY, Ro LS, Lyu RK, Tai YH, Chang HS, Wu YR, Huang CC, Hsu WC, Kuo HC et al (2013) Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis. Clin Chim Acta Int J Clin Chem 417:26\u201330","journal-title":"Clin Chim Acta Int J Clin Chem"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-015-7844-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-015-7844-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-015-7844-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:22:54Z","timestamp":1559056974000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-015-7844-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,11]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["7844"],"URL":"https:\/\/doi.org\/10.1007\/s00415-015-7844-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,11]]}}}